LTRN

Lantern Pharma Inc. LTRN

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$12.02M total
Empery Asset Management, LP
$3.51MNew
CM Management, LLC
$2.08M+100.0%
VANGUARD CAPITAL MANAGEMENT LLC
$1.77M+28.0%
RENAISSANCE TECHNOLOGIES LLC
$1.21M+150.9%
BIOS Capital Management, LP
$1.04M-71.1%
GEODE CAPITAL MANAGEMENT, LLC
$428.9K-7.9%
VANGUARD FIDUCIARY TRUST CO
$208.3K+0.7%
CITADEL ADVISORS LLC
$199.7KNew
Westside Investment Management, Inc.
$199.5K-4.4%
Quadrature Capital Ltd
$165.1KNew
NewEdge Advisors, LLC
$112.8KNew
HORIZON KINETICS ASSET MANAGEMENT LLC
$104.9K-4.6%
DAVENPORT & Co LLC
$99.3K0.0%
STATE STREET CORP
$98.6K0.0%
BlackRock, Inc.
$93.2K-50.6%
Bank of New York Mellon Corp
$88.8K0.0%
NORTHERN TRUST CORP
$72.9K+12.2%
XTX Topco Ltd
$72.6KNew
DIMENSIONAL FUND ADVISORS LP
$69.7K-56.1%
UBS Group AG
$69.4K+65.0%
Focus Partners Wealth
$64.4K0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$58.7KNew
Cetera Investment Advisers
$51.0K0.0%
MARSHALL WACE, LLP
$49.8KNew
Farther Finance Advisors, LLC
$45.8KNew
See all 39 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/LTRN

Earnings Per Share

13fpro.ai/company/LTRN

Loading ratio trend…

LTRN insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Lantern Pharma Inc. (LTRN): stock profile, AI score and financials

Lantern Pharma Inc. (LTRN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. LTRN is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of LTRN by reported 13-F value include Empery Asset Management, CM Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. LTRN trades on the Nasdaq exchange and files with the SEC under CIK 1763950. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LTRN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Lantern Pharma Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1763950 →